13-16 Panel Cups

CLIA Waived refers to a certification under the Clinical Laboratory Improvement Amendments (CLIA)
that allows certain diagnostic tests to be performed easily and safely outside of traditional laboratory
settings, such as in clinics, workplaces, or at home.

Banner Logo

Showing 1–12 of 36 results

13 panel urine drug test
Sale

13 Panel Drug Test Detects Fentanyl 1ng: CLIA Waived & FDA Approved, As Low as $1.59

AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC, FEN 1ng/mlCLIA WAIVEDAs low As$1.59 $1.59 - $2.59
Shop Now This product has multiple variants. The options may be chosen on the product page
13 panel urine test
Sale

13 Panel Test Cup Detecting K2, ETG and FEN, (120ml)- As low as $1.59, Overstock Sale!

AMP, BUP, BZO, COC, EtG, FEN, K2, MET, MTD, OPI/MOR, OXY, PCP, THCForensic UseAs low As$1.59 $1.59 - $2.39
Shop Now This product has multiple variants. The options may be chosen on the product page
13 panel urine test
Sale

13 Panel Drug Test Cup Detects Fentanyl, Low price $1.69

AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, OPI/MOR, OXY, TCA, THCForensic UseAs low As$1.69 $1.69 - $2.49
Shop Now This product has multiple variants. The options may be chosen on the product page
13 panel drug test cup with gab
Sale

13 Panel Drug Testing Cup, Detects Gabapentin, Alcohol & Fentanyl, As Low as $1.59

AMP, BUP, BZO, COC, EtG, FEN, GAB, MET, MTD, OPI/MOR, OXY, PCP, THC, GABAForensic UseAs low As$1.59 $1.59 - $2.39
Shop Now This product has multiple variants. The options may be chosen on the product page
14 drug panel test cup
Sale

14 Panel Drug Test Cup detects Fentanyl, CLIA Waived with EDDP & TCA – Clearance! As low as $1.39

AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, OPI/MOR, OXY, TCA, THC, EDDP, FEN 1ng/mlCLIA WAIVEDAs low As$1.39 $1.39 - $2.29
Shop Now This product has multiple variants. The options may be chosen on the product page
14 Panel Drug test cups with Etg, FEN and PCP
Sale

14 Panel Drug Test Cup detects PCP, (ETG) Alcohol & Fentanyl-120ml Large Cup, As low as $1.79

AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THCForensic UseAs low As$1.79 $1.79 - $2.59
Shop Now This product has multiple variants. The options may be chosen on the product page
13 panel drug test cup with gab
Sale

14 Panel Drug Test Detects GAB, K2, ETG, FEN, Short Date Deal, Expire Date 12/7/26 , Low price of $1.49

AMP, BUP, BZO, COC, EtG, FEN, GAB, K2, MET, MTD, OPI/MOR, OXY, PCP, THC, GABAForensic UseAs low As$1.49 $1.49 - $2.29
Shop Now This product has multiple variants. The options may be chosen on the product page
14 Panel Drug Test Cup With EtG - 12PanelNow employee drug test
Sale

14 Panel Drug Test detects Tramadol, ETG and Fentanyl, As low as $1.79

AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, THC, TRAForensic UseAs low As$1.79 $1.79 - $2.59
Shop Now This product has multiple variants. The options may be chosen on the product page
15 panel drug test cup with gab
Sale

15 Panel Drug Test Detects GAB, FEN, ETG, Short Date Deal, Expire Date 12/07/26, As low as $1.49

AMP, BAR, BUP, BZO, COC, EtG, FEN, GAB, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC, GABAForensic UseAs low As$1.49 $1.49 - $2.29
Shop Now This product has multiple variants. The options may be chosen on the product page
CLIA Waived 15 panel drug test cup
Sale

15 Panel Drug Test Cup Detects Fentanyl, Nor Fentanyl & EDDP, CLIA Waived- Clearance! As low as $1.49

AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, NFEN, OPI/MOR, OXY, PCP, THC, EDDP, FEN 1ng/mlCLIA WAIVEDAs low As$1.49 $1.49 - $2.29
Shop Now This product has multiple variants. The options may be chosen on the product page
13 Panel & 5 Panel & 6 Panel & 7 Panel & 8 Panel & 10 Panel & 12 Panel & 16 Panel & 18 Panel & 14 Panel & 15 Panel & 20 Panel & 21 Panel Multi-Drug Urine Test Cup, 17 Panel, 6 Panel Drug Test Cup, 8 Panel Multi-Drug Urine Test Cup, 10 Panel Drug Test Cup, 10 Panel, 10 Panel Urine Drug Test Cup, 11 panel, Multi-drug Urine 14 Panel, 16 Panel, 15 Panel, 14 Panel
Sale

16 Panel Drug Test Detects Kratom, Alcohol, ETG, TCA and Fentanyl, As low as $1.99

AMP, BAR, BUP, BZO, COC, EtG, FEN, KRA, MDMA, MET, MTD, OPI/MOR, OXY, PCP, TCA, THCForensic UseAs low As$1.99 $1.99 - $2.99
Shop Now This product has multiple variants. The options may be chosen on the product page
13 Panel & 5 Panel & 6 Panel & 7 Panel & 8 Panel & 10 Panel & 12 Panel & 16 Panel & 18 Panel & 14 Panel & 15 Panel & 20 Panel & 21 Panel Multi-Drug Urine Test Cup, 17 Panel, 6 Panel Drug Test Cup, 8 Panel Multi-Drug Urine Test Cup, 10 Panel Drug Test Cup, 10 Panel, 10 Panel Urine Drug Test Cup, 11 panel, Multi-drug Urine 14 Panel, 16 Panel, 15 Panel, 14 Panel
Sale

13 Panel Multi-Drug Urine Test Cup detects ETG, As low as $1.69

AMP, BAR, BUP, BZO, COC, EtG, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THCForensic UseAs low As$1.69 $1.69 - $2.49
Shop Now This product has multiple variants. The options may be chosen on the product page

Features of 13-16 Panel Cups Drug Tests

Non-Invasive, Rapid, and Reliable Alcohol Screening

    • Non-invasive and easy to use — urine-based with no special equipment needed
    • Fast — results in as little as 2–5 minutes
    • Highly reliable — detects even low-level or moderate alcohol consumption
    • Widely used in workplace screening, legal monitoring, clinical settings, and rehabilitation programs
    • Helpful for confirming abstinence or monitoring relapse in individuals undergoing alcohol treatment
    • Compatible for use alongside other drug tests in multi-panel cups or strips

The 13-16 panel drug test cup range is where emerging substance detection begins. Every configuration shares the same 12-substance professional core and adds between one and four panels covering Fentanyl, Gabapentin, Kratom, Tramadol, Synthetic Cannabinoids (K2/K3/K4), Norfentanyl (NFYL), and Ethyl Glucuronide (EtG), the substances responsible for driving programs past a standard 12 panel screen. All cups include a built-in temperature strip and leak-proof lid. Results in 5 minutes at 99% accuracy.

13-16 Panel Cups Specifications

The 13-16 panel tests are designed not only for comprehensive substance detection but also for ease of use and reliability in various settings.

Core 12 Panels Shared Across Every 13 to 16 Panel Configuration

Panel Substance Cutoff Catches
AMP Amphetamines 1000 ng/mL Adderall, Vyvanse
BAR Barbiturates 300 ng/mL Phenobarbital, butalbital
BUP Buprenorphine 10 ng/mL Suboxone, Subutex
BZO Benzodiazepines 300 ng/mL Xanax, Valium, Klonopin
COC Cocaine 300 ng/mL Cocaine, crack cocaine
MDMA Ecstasy / Molly 500 ng/mL MDMA, Ecstasy, Molly
MET/mAMP Methamphetamine 1000 ng/mL Crystal meth, street meth
MTD Methadone 300 ng/mL Methadone maintenance
OPI/MOR Opiates / Morphine 300 ng/mL Heroin, codeine, morphine
OXY Oxycodone 100 ng/mL OxyContin, Percocet
PCP Phencyclidine 25 ng/mL PCP, angel dust
THC Marijuana / Cannabis 50 ng/mL Cannabis, THC products

What Each Configuration Adds to the Core 12 Panels

Product Extended Panels Added Cutoffs Classification From
13 Panel CLIA Waived Cup + FEN (ultra-sensitive) FEN / 1 ng/mL CLIA Waived $1.49
13 Panel Cup with FEN + FEN (standard sensitivity) FEN / 20 ng/mL Forensic Use Only $1.79
13 Panel Cup with Gabapentin + GAB (Gabapentin / Neurontin) GAB / 1000 ng/mL Forensic Use Only $1.59
14 Panel Cup with EtG and FEN
SKU: SM-CDOA-7145FUO
+ FEN + EtG (alcohol metabolite) FEN / 20 ng/mL  |  EtG / 300 ng/mL Forensic Use Only $1.79
14 Panel 90ML Cup with ETG, FEN, TRA and K2
SKU: SM-CDOA-8145EFKTAD3-FUO-90
+ FEN + EtG + TRA (Tramadol) + K2 (90ml) FEN / 20  |  EtG / 300  |  TRA / 100  |  K2 / 50 ng/mL Forensic Use Only Contact for bulk
15 Panel 90ML Cup with FEN, EtG, KRA, NFYL and K2/K3/K4
SKU: SM-CDOA-1154K-FUO-90
+ FEN + EtG + NFYL (Norfentanyl) + KRA (Kratom) + K2/K3/K4 + 3 adulterations FEN/1 or 20 ng/mL  |  EtG/500  |  NFYL/5  |  KRA/500  |  K2/50 ng/mL Forensic Use Only $1.59
16 Panel Cup with KRA, EtG and FEN
SKU: SM-CDOA-8165FUO
+ FEN + EtG + TRA (Tramadol) + KRA (Kratom) FEN / 20 ng/mL  |  EtG / 500 ng/mL  |  TRA / 100 ng/mL  |  KRA / 500 ng/mL Forensic Use Only $1.79

All cups include built-in temperature strip and leak-proof lid. Standard 120ml capacity unless noted as 90ml compact format. Results in 5 minutes. 99% accuracy. CLIA Waived indicated on applicable products. Forensic Use Only (FUO) products are for presumptive screening and should be confirmed by GC-MS or LC-MS/MS before formal action.

13-16 Panel Cups Method

How To Use an 13-16 Panel Cups Drug Test Device

Box 2

1 - Collect

Remove the urine drug test cup from the sealed pouch and use it as soon as possible.

13-16 panel drug test cup

2 - Wait

At 2–4 minutes, verify the temperature of the specimen by observing where the green dot appears.

Box 2

3 - Read

Peel off the label when ready to interpret the results. Test results should be read within 5 minutes.

Positive-1

Positive

Two colored bands appear — one in the control region (C) and one in the test region (T). This indicates no drug was detected above the cutoff level.

Negative-1

Negative

Two colored bands appear, one in the control region (C) and another in the test region (T) for the drug in question.

Invalid-1

Invalid

The control band fails to appear entirely. Discard the test and retest with a fresh cup within 3 minutes. If the problem persists, contact your distributor.

13 to 16 Panel Drug Test Cups: The Emerging Substance Range Where Kratom, Gabapentin, Fentanyl and K2 Join the Standard Professional Lineup

The 13 to 16 panel drug test cup range represents the critical transition in professional urine screening where the standard professional panel coverage of the 12 panel cup expands to include the emerging and resurgent substances that have driven programs to upgrade their screening since 2020. Every configuration in this range shares the same twelve-substance professional core: AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP, and THC. What each higher panel count adds are the substances that a 12 panel cup does not detect at all: Fentanyl (FEN), Gabapentin (GAB), Kratom (KRA), Synthetic Cannabinoids (K2, K3, and K4), Tramadol (TRA), Norfentanyl / NFYL (the primary fentanyl metabolite), and Ethyl Glucuronide (EtG). Each of these substances requires a dedicated antibody panel that is not present in any 12 or lower panel configuration and will not cross-react with any existing standard panel.

The 13 to 16 panel cup range closes the detection gaps that have grown most significantly in US drug testing environments since 2019. Fentanyl is the most pressing gap; Gabapentin and Kratom are the fastest-growing; Tramadol and K2 address documented synthetic substance risks in specific populations. Substances added to the 12-panel base across this range include:

Fentanyl and Fentanyl Metabolite Detection

Fentanyl (FEN) at 20 ng/mL for Forensic Use Only screening (13, 14, and 16 panel FUO products), Fentanyl at 1 ng/mL on the CLIA Waived 13 panel cup, Norfentanyl (NFYL) at 5 ng/mL on the 15 panel 90ML cup for extended fentanyl detection beyond the parent compound window

Gabapentin Detection

Gabapentin (GAB) at 1000 ng/mL, added at the 13 panel level, the most commonly prescribed drug in the US not covered by any standard 12 or lower panel configuration and increasingly misused alongside opioids

Kratom Detection

Kratom (KRA) at 500 ng/mL, added at the 15 and 16 panel level, detecting the herbal stimulant and opioid-like substance sold legally in most US states and widely used in opioid withdrawal self-management contexts

Synthetic Cannabinoids

K2 / Spice at 50 ng/mL (added at 14 and 15 panel level), K3 and K4 synthetic cannabinoid compound variants (15 panel 90ML configuration), none of which appear on a standard THC strip

Tramadol Detection

Tramadol (TRA) at 100 ng/mL, added at the 14 and 16 panel level, a synthetic opioid widely prescribed for pain that does not appear on a standard OPI/morphine or OXY strip

Alcohol Metabolite Detection

Ethyl Glucuronide (EtG) at 300 to 500 ng/mL across the 14 and 16 panel configurations and the 15 panel 90ML, detecting alcohol consumption up to 80 hours post-use from a standard urine collection

The Four Emerging Substances That Drive Programs Past a 12 Panel Screen

The step from a 12 panel cup to a 13, 14, 15, or 16 panel cup is almost always driven by one or more of four specific substance detection requirements that a 12 panel cannot meet. First, Fentanyl: a fully synthetic opioid structurally distinct from the morphine antibody in a standard OPI strip, meaning every standard 12 panel screen has a systematic fentanyl detection gap. Second, Gabapentin: the most prescribed drug in the US that does not appear on any standard panel, with documented concurrent misuse alongside opioids in both pain management and MAT populations. Third, Kratom: a herbal substance that acts on opioid receptors and is widely used as an opioid substitute, sold legally in most US states, and detectable only with a dedicated KRA antibody panel. Fourth, K2/Synthetic Cannabinoids: chemically distinct from THC, requiring a dedicated synthetic cannabinoid immunoassay that will never cross-react with the THC antibody used in standard cannabis panels. Programs that have encountered any of these four substance categories in their testing population will not find a solution within the 12 panel cup range. All four are available across the 13 to 16 panel cup products from 12 Panel Now starting at $1.49 per cup. For broader emerging substance coverage including Ketamine, Xylazine, Tramadol, ZAZA (Tianeptine), and more, explore the 17 to 28 panel cup range. Available in bulk and wholesale quantities with same-day shipping on qualifying orders.

13-16 Panel Cups: Clinical Certification, 1 ng/mL Sensitivity, and the Full Product Range Built for Healthcare Programs

13 to 16 Panel Drug Test Cups: The Emerging Substance Upgrade Range Where Your 12 Panel Program Closes Its Most Critical Detection Gaps: The 13 to 16 panel drug test cup range from 12 Panel Now is where programs that have completed the upgrade from 5 panel to 12 panel take the next step: covering the four substances responsible for the majority of false negatives in current standard professional screening. Fentanyl. Gabapentin. Kratom. K2. Each of these requires a dedicated antibody panel. None appear on any existing standard 12 panel or lower configuration. All are available across this range starting at $1.49 per cup in bulk, with same-day shipping from our US warehouse on every order.

  • Fentanyl at 1ng/mL on the CLIA Waived 13 Panel: Clinical Sensitivity Standard in a Standard Cup: The 13 Panel CLIA Waived Cup detects Fentanyl at 1 ng/mL, the most sensitive FEN threshold available in a point-of-care urine drug screening device. Standard Forensic Use Only 13 and 14 panel cups detect fentanyl at 20 ng/mL. The CLIA Waived version detects it at a threshold twenty times more sensitive, appropriate for pain management compliance monitoring, therapeutic fentanyl confirmation, and diversion detection in clinical programs. CLIA Waived certification allows results to be used for clinical documentation without laboratory confirmation. At as low as $1.49 per cup, it is the most affordable CLIA Waived fentanyl cup configuration in the 12 Panel Now range.
  • Gabapentin at 1000 ng/mL: The Most Commonly Missed Prescription Drug in Standard Screening: The 13 Panel Cup with Gabapentin adds a dedicated GAB panel at 1000 ng/mL to the complete 12 panel professional base. Gabapentin (Neurontin) is the most widely prescribed drug in the United States that does not appear on any standard drug test panel. It is prescribed for nerve pain, seizures, and anxiety, and it is increasingly misused alongside opioids to potentiate the opioid effect. According to NIH research on co-occurring substance use, gabapentin misuse in opioid-using populations has grown significantly in the past five years, making a dedicated GAB panel a standard requirement for any program screening populations with concurrent opioid use. A standard BZO or any other existing panel will not detect gabapentin.
  • Norfentanyl (NFYL) at 5ng/mL: The Extended Fentanyl Detection Window That a FEN-Only Panel Cannot Provide: The 15 Panel 90ML Cup is the only configuration in this range that includes Norfentanyl (NFYL) at 5 ng/mL alongside the FEN panel. Norfentanyl is the primary urinary metabolite of fentanyl and persists in urine for 24 to 72 hours after the parent fentanyl compound has cleared. For programs running weekly or bi-weekly urine drug screens where fentanyl exposure documentation needs to cover the full inter-test interval, NFYL detection closes the detection window gap that a FEN-only panel leaves open. If a patient used illicit fentanyl 48 hours before a test, the FEN parent compound may have cleared. The NFYL metabolite likely has not.
  • Kratom at 500 ng/mL: The First Standard Panel Configuration to Detect the Most Common Opioid Substitute: The 16 Panel Cup with KRA and the 15 Panel 90ML both include Kratom (KRA) at 500 ng/mL. Kratom is an herbal substance derived from the Mitragyna speciosa plant that acts on opioid receptors, is sold legally in most US states, and is widely used by individuals managing opioid withdrawal symptoms without medical supervision. It does not appear on any standard OPI, OXY, BUP, or MTD panel. Programs operating in populations where opioid self-management outside of clinical supervision is a documented pattern will not detect kratom use on any 12 or lower panel configuration. The 15 and 16 panel cups from 12 Panel Now are among the only standard professional cup configurations that include KRA as a dedicated independent panel.
  • K2, K3 and K4 Synthetic Cannabinoids: Three Generations of Synthetic Marijuana That a THC Strip Will Never Catch: K2 (Spice) at 50 ng/mL appears in the 14 Panel 90ML configuration and the 15 Panel 90ML Cup. The 15 panel also adds K3 and K4, two additional synthetic cannabinoid compound classes representing second and third generation Spice formulations. None of these synthetic cannabinoids will cross-react with the THC antibody used in standard cannabis testing. A program that runs a standard 12 panel cup and encounters K2 or Spice use in their population will receive a THC-negative result from someone actively using synthetic marijuana. The dedicated K2/K3/K4 panels are the only detection method for this substance class.
  • Tramadol at 100 ng/mL: A Synthetic Opioid That Falls Through Every Standard OPI and OXY Strip: Tramadol (TRA) is added at the 14 panel 90ML and 16 panel configurations. Tramadol is a synthetic opioid analgesic prescribed for moderate to severe pain. It is one of the most commonly prescribed opioids in the US and does not appear on a standard OPI/MOR or OXY panel because its chemical structure does not cross-react with the morphine or oxycodone antibodies. A dedicated TRA panel at 100 ng/mL is the only reliable urine detection method. For pain management programs and MAT clinics serving populations where tramadol is commonly prescribed, this gap in standard screening is clinically significant.
  • EtG Alcohol Metabolite at 300 to 500 ng/mL: Detecting Alcohol Up to 80 Hours Post-Consumption: Ethyl Glucuronide (EtG) is added in the 14 panel with EtG and FEN, the 14 panel 90ML, and the 16 panel with KRA. EtG detects a urinary metabolite of alcohol that persists for 24 to 80 hours after consumption, compared to the 6 to 12 hour window of a direct BAC test. For court-supervised programs, sober living facilities, and treatment programs running weekly collections, EtG closes the alcohol monitoring gap that any BAC-only test leaves across the inter-test interval.
  • 90ml Compact Format Options: Lower Per-Cup Cost at Higher Panel Counts: Several configurations in the 14 and 15 panel range are available in a compact 90ml format that provides the same panel coverage and result accuracy as the standard 120ml cup at a lower per-cup price point. The 90ml format is particularly practical for high-volume screening programs where storage efficiency and per-test cost optimization are operational priorities alongside expanded substance coverage.
  • Built-In Temperature Strip and Leak-Proof Lid on Every Configuration: Every 13 to 16 panel drug test cup includes a built-in temperature strip for specimen integrity verification and a leak-proof click-top or twist-top lid that prevents contamination during handling. The temperature strip confirms the specimen is within the expected 90 degrees F to 100 degrees F body temperature range at the time of collection, flagging potential substitution immediately without requiring a secondary test.
  • CLIA Waived and FUO Configurations Available: Clinical Documentation and Forensic Use Both Covered: This range includes both CLIA Waived (the 13 Panel CLIA Waived Cup with FEN at 1ng/mL) and Forensic Use Only configurations across the remaining products. CLIA Waived certification permits results to be used for clinical documentation in healthcare settings without laboratory confirmation. Forensic Use Only products produce a presumptive screening result that should be confirmed by GC-MS or LC-MS/MS before formal clinical, legal, or employment action.
  • OEM and Private Label Support Across All Configurations: Build your own branded 13 to 16 panel drug test cup product line with full OEM and private label support from 12 Panel Now. Custom logo, packaging, and cup label design available for distributors, treatment networks, law enforcement supply partners, and drug testing organizations requiring professionally branded emerging-substance screening products.
  • Bulk Wholesale Pricing from $1.49 Per Cup: Beat Any Supplier by 10%: Our 13 to 16 panel drug test cups start at $1.49 for the CLIA Waived 13 panel configuration and scale through to $1.99 for the 16 panel with KRA, EtG and FEN. Tiered wholesale pricing applies at every volume level. Send your current supplier's rate sheet to [email protected] and we will beat it by 10%.
  • Same-Day Shipping on Every Order: Over 8 Million Cups In Stock: Every 13 to 16 panel drug test cup order ships the same day on orders placed before 3:00 PM EST from our US-based warehouse. Over 8 million cups in stock across all configurations. No backorders, no delays at any volume.

Contact for OEM, Private Label and Bulk 13 to 16 Panel Drug Test Cup Orders: 561-897-9238  |  [email protected]

Our 13-16 Panel Cups Variation Comprise of Many Drug Test Devices Such as

Check other product variations and Testing Devices

 

  • Multi Strips
  • 5 Panel Dip Cards
  • 10 Panel Dip Cards
  • 12 Panel Dip Cards
  • 14 Panel Dip Cards
  • 19 Panel Dip Cards

13 Panel Drug CLIA & FEN

View Product

Clia Waived Urine FEN

Shop Swabs

13 Panel Dip Card

View Product

ETG Strips

View Product

Bulk 13 to 16 Panel Drug Test Cups Wholesale: Emerging Substance Detection, US Supplier Pricing from $1.49, Same-Day Shipping

Partnering with 12 Panel Now for your 13 to 16 panel drug test cup supply means working with the US manufacturer that has the widest range of emerging-substance cup configurations available at competitive bulk pricing. Whether you need the 13 Panel CLIA Waived Cup at $1.49 for clinical fentanyl monitoring, the 13 Panel Gabapentin Cup at $1.59 for programs screening co-occurring gabapentin misuse, the 14 Panel EtG and FEN Cup at $1.79 for combined alcohol and fentanyl detection, the 15 Panel 90ML for synthetic cannabinoid coverage across three compound classes plus norfentanyl, or the 16 Panel Cup with KRA at $1.79 for the most comprehensive emerging-substance coverage in this range, we have every configuration in stock and ready to ship today.

  • Thirteen to sixteen panels. Fentanyl. Gabapentin. Kratom. K2. Tramadol. Norfentanyl. Alcohol metabolite. The four substances your 12 panel misses, closed, in one cup, from $1.49. Same-day shipping. Best price guaranteed.

Contact Us for a Personalized 13 to 16 Panel Cup Wholesale and Private Label Plan  561-897-9238  [email protected]

Order your 13 to 16 panel drug test cups today. The emerging substance range where Fentanyl, Gabapentin, Kratom, and K2 join the professional standard lineup, starting from $1.49 per cup. Same-day shipping. Best price guaranteed. Contact us and place your order today.

Why 12 Panel Now Beats Any Other Supplier In the Market

SVG-1

220,000 Sq. Ft. Mega
Warehouse

We operate one of the largest drug-testing fulfillment centers in the country, stocked and ready to ship every day.

SVG-3

Lowest Wholesale Pricing. Highest Commissions. Period.

We aggressively price our products so you win more deals, while paying industry-leading commissions to our partners.

SVG-2

Same-Day Blind Drop Shipping

We ship directly to your customers — no branding, no invoices, no paper trail back to us. You keep the relationship. We do the heavy lifting.

SVG-1

Private Label Available

Want your own brand on the box? We’ve got you covered.
Build equity while selling proven products.

SVG-3

Real-Time Partner Portal

Track every order, commission, and customer in one clean dashboard. No guessing. No spreadsheets. Total transparency.

Where 13-16 Panel Cups Are Used: Clinical, Healthcare, and Compliance Settings

Setting Best Configuration Primary Applications Why This Configuration
Pain Management Clinics 13 Panel CLIA Waived or 13 Panel GAB Fentanyl compliance monitoring at clinical sensitivity, gabapentin concurrent use detection, prescription opioid compliance verification, co-prescribed medication monitoring The CLIA Waived 13 Panel Cup at 1ng/mL FEN is the clinical standard for fentanyl compliance documentation in pain management. The GAB Cup adds the most commonly co-prescribed and co-misused substance in chronic pain populations. SAMHSA guidelines require CLIA compliant testing for clinical documentation in opioid treatment programs.
MAT and Addiction Treatment Programs 14 Panel EtG and FEN or 15 Panel 90ML BUP and MTD compliance monitoring, concurrent fentanyl use detection, alcohol abstinence monitoring via EtG, norfentanyl extended-window fentanyl detection, gabapentin concurrent use Fentanyl contamination of illicit drug supply is the primary overdose risk for MAT patients who also use illicit substances. EtG at 300-500 ng/mL closes the alcohol monitoring gap across weekly testing intervals. The 15 Panel 90ML adds NFYL for extended fentanyl detection and KRA for kratom self-management detection. Per SAMHSA MAT guidelines, concurrent substance monitoring is a program compliance standard.
Correctional Facilities 13 Panel FEN or 16 Panel KRA Fentanyl contraband detection, K2/Synthetic Marijuana institutional screening, Kratom contraband detection, comprehensive BUP diversion monitoring, alcohol detection, full stimulant and opioid class coverage Fentanyl and synthetic cannabinoids are the two most commonly seized contraband substance categories in US correctional facilities. Neither appears on a standard 12 panel screen. The 16 Panel Cup adds FEN, K2, and KRA alongside the complete opioid, stimulant, and sedative lineup for the most complete contraband detection profile available in a standard urine cup at this price point. The Bureau of Justice Assistance identifies fentanyl as the leading substance-related safety risk in institutional correctional environments.
Drug Courts and Probation Programs 14 Panel EtG and FEN or 16 Panel KRA Court-ordered comprehensive multi-substance compliance monitoring, alcohol abstinence verification via EtG across the inter-test interval, fentanyl and kratom detection for court supervision populations The 14 panel EtG and FEN configuration covers alcohol compliance (EtG for 80-hour detection vs 12-hour BAC test) and fentanyl alongside the complete professional baseline for participants with alcohol and multi-substance conditions. The 16 panel adds KRA for courts where kratom self-management is a documented pattern. The NADCP best practice standards recommend multi-class substance monitoring including emerging drug classes in court-supervised programs.
Sober Living and Residential Recovery 13 Panel GAB or 14 Panel EtG and FEN Resident accountability screening, gabapentin diversion and misuse detection, fentanyl relapse risk monitoring, alcohol abstinence documentation, BUP compliance for MAT-enrolled residents Gabapentin is widely available in recovery residential settings and is used by some individuals to self-medicate withdrawal or to amplify the effect of low doses of illicit substances. The 13 Panel GAB Cup adds this detection capability to the complete professional baseline at $1.59, making it the most cost-effective way to close this specific gap in standard residential screening programs. Per NIH research, gabapentin misuse in opioid recovery populations is a documented and growing clinical concern.

Why Programs Are Upgrading from 12 Panel Drug Test Cups to 13 Panel: The Four Substances Driving the Switch in 2026

There are four substances that have driven the majority of upgrades from 12 panel to 13 panel and higher drug test cups in the US market since 2020. Fentanyl. Gabapentin. Synthetic Marijuana (K2). Kratom. Each represents a substance class that is absent from every 12 and lower panel cup configuration, requires a dedicated antibody panel to detect, and has grown in documented prevalence across workplace, treatment, and compliance populations in the last five years.

Every standard 12 panel cup screen has a systematic fentanyl blind spot that produces negative results for individuals who have recently used illicit fentanyl. The 13 Panel Cup with FEN closes this gap at 20 ng/mL for Forensic Use Only programs. The 13 Panel CLIA Waived Cup closes it at 1 ng/mL for clinical programs that need documentation-grade results. According to CDC overdose surveillance data, fentanyl is now detected in the majority of US drug overdose deaths across all substance categories. The 13 Panel Cup with Gabapentin adds GAB at 1000 ng/mL at $1.59 per cup, making it the most cost-effective way to close this specific detection gap without changing any other aspect of a program's screening configuration. For programs that need both fentanyl and gabapentin detection, the step to the 15 and 16 panel range covers both alongside kratom, K2, and EtG.

16 Panel Drug Test Cup with Kratom, Fentanyl and Alcohol: The Most Comprehensive Standard-Range Urine Cup for High-Risk Program Populations

The 16 Panel Drug Test Cup with KRA, EtG and FEN from 12 Panel Now adds four substances that no standard 12 panel cup detects to the complete twelve-substance professional baseline: Fentanyl (FEN) at 20 ng/mL, Ethyl Glucuronide (EtG) at 500 ng/mL for alcohol metabolite detection, Tramadol (TRA) at 100 ng/mL, and Kratom (KRA) at 500 ng/mL. These four additions cover the substance classes most commonly responsible for false-negative results in programs operating in high-risk opioid and emerging-substance environments, in a single cup that starts at $1.79 per cup in bulk from 12 Panel Now.

Fentanyl does not appear on a standard OPI strip and requires a dedicated FEN panel. EtG detects alcohol consumption for 24 to 80 hours post-use, closing the monitoring gap between scheduled collection dates that a standard BAC test cannot cover. Tramadol is a synthetic opioid prescribed for pain that does not cross-react with OPI or OXY antibodies, making it structurally invisible to every 12 and lower panel cup. The dedicated KRA panel at 500 ng/mL is the only reliable detection method for kratom use in urine screening. Together, these four panels address the specific substance risk profile of drug courts and probation programs, correctional facilities, and high-risk MAT and addiction treatment programs where standard 12 panel screening has the highest documented false-negative rate.

The 16 Panel Cup is available in bulk at $1.79 per cup from 12 Panel Now with same-day shipping and wholesale pricing at every volume level. Full OEM and private label support is available for programs that need a branded 16 panel cup product. Programs that need to go beyond 16 panels to include Xylazine, Ketamine, ZAZA (Tianeptine), or Gabapentin alongside this core substance profile should evaluate the 17 to 28 panel cup range which covers these additional substances across several configurations starting at $1.89 per cup.

What does "CLIA and FUO" mean?

  • What it means:CLIA Waived only tests determine program compliance - whether someone violated probation conditions, sober living rules, or custody requirements. They do not diagnose substance use disorder or guide medical treatment. Many courts require laboratory confirmation (GC-MS or LC-MS/MS) before admitting screening results as evidence.All results obtained from CLIA Waived & Fentanyl Drug Test Method tests should be treated as preliminary screening results only and must be confirmed by a certified laboratory using GC-MS (Gas Chromatography-Mass Spectrometry) or LC-MS/MS methodology before any legal, disciplinary, or medical action is taken.

 

  • How results are used: Forensic use only tests determine program compliance - whether someone violated probation conditions, sober living rules, or custody requirements. They do not diagnose substance use disorder or guide medical treatment. Many courts require laboratory confirmation (GC-MS or LC-MS/MS) before admitting screening results as evidence.
  • What it means: The product has not undergone FDA 510(k) clearance - the premarket notification process for medical devices. The FDA exercises enforcement discretion over these products because forensic settings have evidentiary protections (rules of evidence, chain of custody, confirmation requirements) not present in clinical settings.

13-16 Panel Cups Test Method Frequently Asked Questions

A 16-panel cup includes additional substances such as Kratom, Tramadol, EtG, or other emerging drugs that may not be included in a standard 13-panel configuration.

CLIA Waived tests are designed for use in healthcare and point-of-care settings where simplified testing procedures are required.

Yes, many employers use multi-panel cups for rapid workplace drug screening programs.

Gabapentin testing may be used when monitoring populations where prescription medication misuse is a concern.

The temperature strip helps verify that the sample was freshly provided and falls within an expected temperature range.

These cups are often used in healthcare, treatment programs, corrections, probation monitoring, and workplace testing.

Tramadol may not be detected by traditional opiate tests, making a dedicated panel necessary.

Programs should consider their testing goals, substances of concern, compliance requirements, and budget.

Positive results should be confirmed when legal, employment, disciplinary, or clinical decisions depend on the outcome.

Many suppliers offer OEM and private-label options for organizations that want branded testing products

EtG detects an alcohol metabolite that remains in urine longer than alcohol itself, helping identify recent alcohol consumption.

Fentanyl is a highly potent synthetic opioid that may not be detected by standard opiate panels without a dedicated fentanyl test strip.

Norfentanyl is the primary metabolite of fentanyl and can help extend the detection window after fentanyl use.

Kratom requires its own dedicated test panel because it does not trigger standard opioid screening antibodies.

Yes, cup size does not affect test accuracy when the device is used according to the manufacturer's instructions.

Synthetic cannabinoids such as K2 have different chemical structures and require dedicated testing panels.

Yes, they are commonly used for large-scale screening due to their rapid results and easy administration.

They should generally be stored according to the manufacturer's recommended temperature and humidity guidelines.

They help prevent spills, contamination, and specimen handling issues during collection and transport.

Reviewing current substance trends, program requirements, and historical testing data can help identify the most appropriate panel configuration.